+ Create post

Corteva settles Inari seed-IP case, with licensing talks still pending

Corteva ($CTVA) and Inari have reached a confidential settlement of Corteva’s seed-related intellectual-property lawsuit in Delaware. Inari agreed to destroy Corteva material accessed through seed depositories, together with material developed from those deposits. It also agreed to transfer intellectual property associated with its edited versions of Corteva’s proprietary genetic events to Corteva. The settlement resolves litigation over control of biological material and related innovations, an

0
0

Corteva clears SEC registration milestone for Vylor separation

Corteva ($CTVA) said the SEC declared Vylor’s Form 10 registration statement effective, advancing the planned separation of its seed and genetics business. Eligible Corteva shareholders are scheduled to receive one Vylor share for each Corteva share through the distribution planned for October 1. Vylor has been authorized for a New York Stock Exchange listing under the symbol VYLR. The registration milestone is a new step in a previously announced separation, rather than a newly negotiated sale

0
0

Chemours, DuPont and Corteva agree to a $455 million PFAS settlement

Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Chemours will bear half of the total, with DuPont and Corteva responsible for the remaining half under their existing allocation arrangements. Chemours estimated the present value of its share at approximately $180 million and said that amount is covered by exist

0
0